Karyopharm Therapeutics Inc (KPTI)
0.814
-0.02
(-2.78%)
USD |
NASDAQ |
Nov 15, 16:00
0.81
0.00 (0.00%)
After-Hours: 07:47
Karyopharm Therapeutics Gross Profit Margin (Quarterly): 96.65% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 96.65% |
| June 30, 2024 | 96.58% |
| March 31, 2024 | 94.23% |
| December 31, 2023 | 95.60% |
| September 30, 2023 | 97.47% |
| June 30, 2023 | 96.82% |
| March 31, 2023 | 96.51% |
| December 31, 2022 | 94.44% |
| September 30, 2022 | 97.29% |
| June 30, 2022 | 97.63% |
| March 31, 2022 | 97.01% |
| Date | Value |
|---|---|
| December 31, 2021 | 99.41% |
| September 30, 2021 | 98.44% |
| June 30, 2021 | 94.96% |
| March 31, 2021 | 95.99% |
| December 31, 2020 | 97.00% |
| September 30, 2020 | 97.95% |
| June 30, 2020 | 98.82% |
| March 31, 2020 | 95.48% |
| December 31, 2019 | 92.30% |
| September 30, 2019 | 92.30% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
92.30%
Minimum
Dec 2019
99.41%
Maximum
Dec 2021
96.53%
Average
96.74%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 48.45% |
| Ionis Pharmaceuticals Inc | 99.20% |
| Apellis Pharmaceuticals Inc | 82.95% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -39.11% |
| Return on Invested Capital | -221.9% |
| Profit Margin (Quarterly) | -82.70% |
| Operating Margin (Quarterly) | -67.77% |
| Return on Net Operating Assets | -213.9% |